FindMyKOL
Clinical trialNCT04190927UnknownPhase 4Interventional

A New Hormone Replacement Paradigm: Physiologic Restoration Study

NCT04190927 is a phase 4 interventional trial sponsored by Women's Hormone Network. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Compounded topical estradiol and compounded topical progesterone in a carrier cream in Menopause, Menopause Related Conditions and 1 more condition. The registry lists an enrollment of 100 participants. The registry lists a start date of 1 Jun 2020 and a primary completion date of 1 Jun 2023.

SponsorWomen's Hormone NetworkEnrollment100MenopauseMenopause Related ConditionsPerimenopausal Disorder
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04190927
FieldValue
Registry IDNCT04190927
StatusUnknown
PhasePhase 4
Study typeInterventional trial
Lead sponsorWomen's Hormone Network
Enrollment100
ConditionsMenopause, Menopause Related Conditions and Perimenopausal Disorder
DrugsCompounded topical estradiol and compounded topical progesterone in a carrier cream
Start1 Jun 2020
Primary completion1 Jun 2023
Study completion1 Aug 2023
Last update posted1 Apr 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a three-year, prospective, observational study looking at the benefits of rhythmically dosed, bio-identical hormones compounded in a carrier cream in 100 symptomatic peri and postmenopausal women. This study will measure changes in cognition, mood, quality of life, endocrine health, bone mineral density, and reduction of the symptoms of menopause and any adverse effects. The objectives of this study are to show that rhythmic dosing of bio-identical hormones that mimic a menstrual cycle, are possible, and may be more beneficial and have fewer side effects than the current standard of care for treating the symptoms of menopause.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Compounded topical estradiol and compounded topical progesterone in a carrier cream
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT04190927

Each answer restates registry values shown on this page.

What is NCT04190927?

NCT04190927 is a phase 4 interventional trial sponsored by Women's Hormone Network. It studies Compounded topical estradiol and compounded topical progesterone in a carrier cream in Menopause, Menopause Related Conditions and 1 more condition.

Who leads NCT04190927?

The registry names Julie Taguchi, MD (principal investigator, Principal Investigator) as the overall official.

Which drugs does NCT04190927 study?

The registered drug and biological interventions are Compounded topical estradiol and compounded topical progesterone in a carrier cream.

When is NCT04190927 expected to complete?

The registry lists a primary completion date of 1 Jun 2023 and a study completion date of 1 Aug 2023. The sponsor last updated the record on 1 Apr 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.